← Leaderboards
Qingsheng Li
University Of Louisville
$1,280,856
Attributed
$1,280,856
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $273K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,280,856 · 2
By mechanism
P20$1,280,856 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- Thomas Lyman Abell$7,534,832
- Kavitha Yaddanapudi$3,421,422
- Juliane I Beier$3,751,134
- Shirish S Barve$19,574,914
- Jun Yan$16,605,525
Others in their field
Other Emerging Leaders on “Anti-Pd-1”
- John Freymann · Leidos Biomedical Research, Inc.$5,261,900
- Tina Garyantes · Linnaeus Therapeutics, Llc$5,000,000
- Amaia Lujambio · Icahn School Of Medicine At Mount Sinai$4,251,878
- Alexander Huang · University Of Pennsylvania$3,639,634
- Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill$3,602,417
- Jun Wang · New York University School Of Medicine$3,408,076
Research focus
Anti-Pd-1Anti-Pd1 TherapyAnti-Pd1 AntibodiesBioinformaticsBiopsy SpecimenCancer CenterCancer ImmunotherapyCancer ModelCancer PatientCd3 AntigensCd8b1 GeneCd8-Positive T-LymphocytesCellsCheckpoint TherapyClinicClinically RelevantCommensal BacteriaCytotoxicCytotoxicityDesignFailureFda ApprovedGenerationsGerm-Free
Grant awards (5)
Mechanisms of resistance to immune therapy in NSCLC$215,604
P20 · FY2024 · GM · contact PI
Mechanisms of resistance to immune therapy in NSCLC$251,146
P20 · FY2023 · GM · contact PI
Mechanisms of resistance to immune therapy in NSCLC$269,874
P20 · FY2022 · GM · contact PI
Mechanisms of resistance to immune therapy in NSCLC$271,232
P20 · FY2021 · GM · contact PI
Mechanisms of resistance to immune therapy in NSCLC$273,000
P20 · FY2020 · GM · contact PI